Company / Total Debt
MARAVAI LIFESCIENCES HOLDINGS, INC. Total Debt History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$291.8M
FY2025
5-year range
$291.8M / $530.6M
FY2021-FY2025
Trend
-1.4%
vs FY2024
Sector context
#37 of 83
Health Care
What the data says
At $292M, MARAVAI LIFESCIENCES HOLDINGS, INC.'s total debt ranks #47 of 83 in the Health Care sector. Total Debt has declined for 4 consecutive years, from $531M in FY2021 to $292M in FY2025.
Based on SEC 10-K filings.
$292M in FY2025 with a 5-year CAGR of -6.1%.
Improved from $524M to $292M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -17.9%
- 5-Year CAGR
- -6.1%
- 10-Year CAGR
- -
Sector benchmark
#47 of 83 in Health CareTop 55% of 83This company $291.8M Sector average $6.2B
▼
-95.3% below sector average
Key checks
Key Insights
- MARAVAI LIFESCIENCES HOLDINGS, INC.'s total debt has declined for 4 consecutive years.
- 5-year CAGR of -6.1%, indicating a declining trend.
- In FY2025, total debt decreased 1.4% year-over-year.
- Ranks #37 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $291.8M | -1.4% |
| FY2024 | $295.9M | -43.5% |
| FY2023 | $524.1M | -0.6% |
| FY2022 | $527.4M | -0.6% |
| FY2021 | $530.6M | +32.6% |
| FY2020 | $400.0M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026